Jha will lead the human resources function globally, and also head corporate communications and administration for the company.
Prabir Jha, the former group CHRO of Reliance Industries is all set to join the pharmaceuticals major, CIPLA, as global chief people officer. In addition to providing leadership to the human resources function, globally, for the company, he will lead the corporate communications and administration functions as well.
Jha had told HRKatha earlier that he was looking at a more strategic role, which went beyond just human resources.
For Jha, this will be his second stint with a pharmaceuticals firm. He has spent almost eight years at Dr Reddy’s Laboratories, as senior vice-president and global head-HR & corporate communications.
In an official communique, executive director, Samina Vaziralli, who has been interim head of HR says, “We truly believe, focussing and building on human capital is one of the ultimate sources of sustainable, competitive advantage. Having Jha on our executive leadership team, to help us steer this agenda will ensure that our commitment to cutting edge people practices is at the heart of everything we do at Cipla.”
Jha has had an interesting career profile. An alumnus of St Stephen’s College, Delhi, Jha started off as a gazetted government officer with the Indian Ordnance Factories Service and continued there for over eight years. In this role, he led the human resources, industrial relations and administration of various Ordnance Factories in the country.
In 1997, he decided to pursue further studies, which took him to XLRI, after which he moved to the corporate sector. Since then, he has worked with companies, such as Thermax Babcock & Wilcox, Tech Mahindra, Dr Reddy’s, Tata Motors, and then Reliance Industries, where he is known to have introduced several people-friendly measures.
The company informed BSE on the evening of September 1, that Jha will resume his new role from October 1.
CIPLA has had another senior-level appointment in Umang Vohra, who will join as global chief financial and strategy officer. Vohra also moves from Dr Reddy’s Laboratories, where he was head of the North America business.